A comprehensive neuroimaging review of the primary and metastatic brain tumors treated with immunotherapy: current status, and the application of advanced imaging approaches and artificial intelligence
Cancer immunotherapy has emerged as a novel clinical therapeutic option for a variety of solid tumors over the past decades. The application of immunotherapy in primary and metastatic brain tumors continues to grow despite limitations due to the physiological characteristics of the immune system wit...
Saved in:
| Main Authors: | Xiang Liu, Hongyan Chen, Guirong Tan, Lijuan Zhong, Haihui Jiang, Stephen M. Smith, Henry Z. Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1496627/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic pitfall of pseudoprogression after epcoritamab treatment
by: Osamu Imataki, et al.
Published: (2024-12-01) -
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
by: Liv Cathrine Heggebø, et al.
Published: (2025-01-01) -
Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition
by: Yikun Li, et al.
Published: (2024-12-01) -
Progress in immunotherapy for brain metastatic melanoma
by: Shicheng Zheng, et al.
Published: (2025-01-01) -
Pseudoprogression in CAR-T cell therapy for solid tumor: Case report
by: Xuan Zhao, et al.
Published: (2025-01-01)